Protect Your Good Health with a Lifeline Screening

 Lifeline Screening is a health company offering reduced cost health screenings that can pinpoint certain disease processes. Fortunately, most of those individuals that have the screening completed do not have positive results. When some adverse health conditions are indicated by this comprehensive screening, it usually is caught in the early phases, prior to when symptoms arise. The benefits of truly knowing your health story is that people can begin treatment right away. Another benefit is that individuals can start to be in front of any harmful health condition. This test is noninvasive, using standard and higher tech sonograms, electronic devices, lab work, specific healthcare machines, routine vital sign items and other such equipment.

There is nothing fearful about any of the testing through a Lifeline Screening. No bothersome preparations that leave one feeling horribly weak are ever required for this screening style. The screening can pick up endocrine issues, kidney dysfunction, heart related problems, peripheral vascular conditions, neurological defects, diabetes, some forms of cancer and abdominal or intestinal problems. There are other things that this Lifeline Screening can reveal as well. Standard vital signs are taken, and this includes temperature, blood pressure, heart rate – pulse, height and weight plus bone density scan.

Pretending that healthcare conditions don’t exist doesn’t make it go away. Avoiding prevention testing for health status does not keep diseases and other health related concerns away. By knowing your state of total health, steps to move towards better health can begin without delay. Individuals get their Lifeline Screening test results in up to three weeks time. Results are placed into a privacy envelope and sent straight to tested subject’s home. This is terrific, as the person does not have to travel or wait to see a physician. It is a good idea though, to show these results to a healthcare physician.

A Lifeline Screening can simply reassure individuals that they are in a good healthy state. Worry over physical conditions can be taxing for individuals. When specific health conditions are seen within family lines, an individual can now test for the possibly hereditary condition. Friendly representatives are waiting for individual’s questions, and they are a fantastic resource for determining what should be tested for in each screening subject’s unique case. Many top doctors are now seeing the vast benefits of early health prevention screens and tests. Call today to book a time for your Lifeline Screening. Visit: http://www.lifelinescreeningwellness.com/

Clay Siegall: Biotech Boss

Clay B. Siegall, Ph.D., is a scientist and the man behind Seattle Genetics. Having co-founded it in 1998, he currently serves as the business’ president, CEO, (chief executive officer) and chairman of the board. Siegall’s areas of expertise concerns targeted cancer therapies.

Passionate about helping patients, he co-created Seattle Genetics on the precepts of drug development practices, research, and scientific innovation.

His company leads the way in developing ADCs (antibody-drug conjugates) and in earning FDA (food and drug administration) approval for Adcetris (brentuximab vedotin), their first ADC product, in 2011. He and his company worked with the Takeda Pharmaceutical Company to make Adcetris a worldwide brand that is now greenlighted for use in over 60 countries. They are also working on a number of proprietary ADCs in order to treat cancer.

Doctor Siegall and Seattle Genetics have several specific licenses for their ADC technology as well. They have garnered over $325 million with AbbVie, Genentech (Roche), Pfizer, and GlaxoSmithKline. Thanks to both collaborative and internal efforts, there are presently at least 20 ADCs being clinically developed via the use of Seattle Genetics’ technology. Dr. Siegall is also widely credited for the company’s capital-raising efforts which have brought in over $1.2 billion through private and public financings such as their initial public offering which was launched in 2001.

After he earned his Ph.D. in Genetics from George Washington University, but before the beginnings of Seattle Genetics, Doctor Siegell was employed by Bristol-Myers Squibb Pharmaceutical Research Institute from 1991 to 1997. He also worked for the National Cancer Institute and National Institutes of Health from 1988 to 1991. Siegall has been honored with a number of different awards such as the 2012 Pacific Northwest Ernst & Young Entrepreneur of the Year and the 2013 University of Maryland Alumnus of the Year for Computer, Math and Natural Sciences. At present, he sits on the Boards of Directors of Alder BioPharmaceuticals, the Washington Roundtable, and Ultragenyx Pharmaceutical.